Astrana Health Files Form 12b-25 Citing Material Weakness After $745M Prospect Health Acquisition
Astrana Health disclosed material weakness in internal financial controls on March 1, 2026, filing Form 12b-25 to delay quarterly results eight months after closing its $745M Prospect Health acquisition. The filing raises integration concerns that typically precede earnings revisions and goodwill impairment charges in healthcare services sector mergers.
ViaNews Editorial Team (Markets)•